OncoInv is a multi-cancer detection technology provider enabling structured, program-based cancer detection in underserved markets worldwide. Built around OncoSeek®—a validated tool generating cancer probability scores across nine high-impact cancer types—OncoInv operates an asset-light model: licensing technology to authorised distribution and clinical partners rather than owning lab infrastructure. This approach unlocks emerging markets where single-cancer screening is inaccessible and late-stage diagnosis remains the norm. OncoInv's evidence base is peer-reviewed and published. The company has established an initial international footprint across multiple countries and income settings, with expansion underway in Southeast Asia and the Middle East.